← Leaderboards
Sue Kirkman
Indiana Univ-Purdue Univ At Indianapolis
$74,019
Attributed
$74,019
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$74,019 · 3
By mechanism
M01$74,019 · 3
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- David Grayson Marrero$13,650,612
- Helmut O Steinberg$131,165
- John Howard Pratt$5,209,827
- Munro Peacock$2,764,841
- Alain D Baron$796,609
Others in their field
Top investigators on “Noninsulin Dependent Diabetes Mellitus”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$69,532,406
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,288,043
- Mark Andrew Espeland · Wake Forest University Health Sciences$18,466,667
- C Ronald Kahn · Joslin Diabetes Center$17,946,199
- F. Xavier Pi-Sunyer · Columbia University Health Sciences$13,600,448
- David M Nathan · Massachusetts Institute Of Technology$13,352,064
Research focus
Noninsulin Dependent Diabetes MellitusDiabetes Mellitus TherapyClinical ResearchDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationClinical TrialsDiabetes RiskDietary ControlDisease /Disorder OnsetDisease /Disorder Prevention /ControlDrug Administration Rate /DurationGlucagonHormone InhibitorHormone MetabolismHyperglycemiaHypoglycemic AgentsInsulinInsulin Sensitivity /ResistanceMedical ComplicationNutrition Related TagPancreatic Islet FunctionPathologic ProcessPatient Oriented Research
Grant awards (9)
EARLY DIABETES INTERVENTION PROGRAM (EDIP)$17,451
M01 · FY2005 · RR
Early Diabetes Intervention Program (EDIP)$56,568
M01 · FY2004 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2002 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2001 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
GLUCAGON RECEPTOR ANTAGONIST IN TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR